WFRF:(Carey S. K.)
Sökning: WFRF:(Carey S. K.) > (2015-2019) > De-escalating and e...
- 20 av 35
- Föregående post
- Nästa post
- Till träfflistan
| Fältnamn | Indikatorer | Metadata |
|---|---|---|
| 000 | 05483naa a2200961 4500 | |
| 001 | oai:gup.ub.gu.se/256677 | |
| 003 | SwePub | |
| 008 | 240528s2017 | |||||||||||000 ||eng| | |
| 009 | oai:prod.swepub.kib.ki.se:136351658 | |
| 024 | 7 | a https://gup.ub.gu.se/publication/2566772 URI |
| 024 | 7 | a https://doi.org/10.1093/annonc/mdx3082 DOI |
| 024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1363516582 URI |
| 040 | a (SwePub)gud (SwePub)ki | |
| 041 | a eng | |
| 042 | 9 SwePub | |
| 072 | 7 | a ref2 swepub-contenttype |
| 072 | 7 | a art2 swepub-publicationtype |
| 100 | 1 | a Curigliano, G4 aut |
| 245 | 1 0 | a De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. |
| 264 | 1 | b Elsevier BV,c 2017 |
| 520 | a The 15th St. Gallen International Breast Cancer Conference 2017 in Vienna, Austria reviewed substantial new evidence on loco-regional and systemic therapies for early breast cancer. Treatments were assessed in light of their intensity, duration and side-effects, seeking where appropriate to escalate or de-escalate therapies based on likely benefits as predicted by tumor stage and tumor biology. The Panel favored several interventions that may reduce surgical morbidity, including acceptance of 2mm margins for DCIS, the resection of residual cancer (but not baseline extent of cancer) in women undergoing neoadjuvant therapy, acceptance of sentinel node biopsy following neoadjuvant treatment of many patients, and the preference for neoadjuvant therapy in HER2 positive and triple-negative, stage II and III breast cancer. The Panel favored escalating radiation therapy with regional nodal irradiation in high-risk patients, while encouraging omission of boost in low-risk patients. The Panel endorsed gene expression signatures that permit avoidance of chemotherapy in many patients with ER positive breast cancer. For women with higher risk tumors, the Panel escalated recommendations for adjuvant endocrine treatment to include ovarian suppression in premenopausal women, and extended therapy for postmenopausal women. However, low-risk patients can avoid these treatments. Finally, the Panel recommended bisphosphonate use in postmenopausal women to prevent breast cancer recurrence. The Panel recognized that recommendations are not intended for all patients, but rather to address the clinical needs of the majority of common presentations. Individualization of adjuvant therapy means adjusting to the tumor characteristics, patient comorbidities and preferences, and managing constraints of treatment cost and access that may affect care in both the developed and developing world. | |
| 650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
| 650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
| 700 | 1 | a Burstein, H J4 aut |
| 700 | 1 | a P Winer, E4 aut |
| 700 | 1 | a Gnant, M4 aut |
| 700 | 1 | a Dubsky, P4 aut |
| 700 | 1 | a Loibl, S4 aut |
| 700 | 1 | a Colleoni, M4 aut |
| 700 | 1 | a Regan, M M4 aut |
| 700 | 1 | a Piccart-Gebhart, M4 aut |
| 700 | 1 | a Senn, H-J4 aut |
| 700 | 1 | a Thürlimann, B4 aut |
| 700 | 1 | a André, F4 aut |
| 700 | 1 | a Baselga, J4 aut |
| 700 | 1 | a Bergh, Ju Karolinska Institutet4 aut |
| 700 | 1 | a Bonnefoi, H4 aut |
| 700 | 1 | a Y Brucker, S4 aut |
| 700 | 1 | a Cardoso, F4 aut |
| 700 | 1 | a Carey, L4 aut |
| 700 | 1 | a Ciruelos, E4 aut |
| 700 | 1 | a Cuzick, J4 aut |
| 700 | 1 | a Denkert, C4 aut |
| 700 | 1 | a Di Leo, A4 aut |
| 700 | 1 | a Ejlertsen, B4 aut |
| 700 | 1 | a Francis, P4 aut |
| 700 | 1 | a Galimberti, V4 aut |
| 700 | 1 | a Garber, J4 aut |
| 700 | 1 | a Gulluoglu, B4 aut |
| 700 | 1 | a Goodwin, P4 aut |
| 700 | 1 | a Harbeck, N4 aut |
| 700 | 1 | a Hayes, D F4 aut |
| 700 | 1 | a Huang, C-S4 aut |
| 700 | 1 | a Huober, J4 aut |
| 700 | 1 | a Hussein, K4 aut |
| 700 | 1 | a Jassem, J4 aut |
| 700 | 1 | a Jiang, Z4 aut |
| 700 | 1 | a Karlsson, Per,d 1963u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för onkologi,Institute of Clinical Sciences, Department of Oncology4 aut0 (Swepub:gu)xkperd |
| 700 | 1 | a Morrow, M4 aut |
| 700 | 1 | a Orecchia, R4 aut |
| 700 | 1 | a Osborne, K C4 aut |
| 700 | 1 | a Pagani, O4 aut |
| 700 | 1 | a Partridge, A H4 aut |
| 700 | 1 | a Pritchard, K4 aut |
| 700 | 1 | a Ro, J4 aut |
| 700 | 1 | a Rutgers, E J T4 aut |
| 700 | 1 | a Sedlmayer, F4 aut |
| 700 | 1 | a Semiglazov, V4 aut |
| 700 | 1 | a Shao, Z4 aut |
| 700 | 1 | a Smith, I4 aut |
| 700 | 1 | a Toi, M4 aut |
| 700 | 1 | a Tutt, A4 aut |
| 700 | 1 | a Viale, G4 aut |
| 700 | 1 | a Watanabe, T4 aut |
| 700 | 1 | a Whelan, T J4 aut |
| 700 | 1 | a Xu, B4 aut |
| 710 | 2 | a Karolinska Institutetb Institutionen för kliniska vetenskaper, Avdelningen för onkologi4 org |
| 773 | 0 | t Annals of oncology : official journal of the European Society for Medical Oncologyd : Elsevier BVg 28:8, s. 1700-1712q 28:8<1700-1712x 1569-8041 |
| 773 | 0 | t Annals of Oncologyd : Elsevier BVg 28:8, s. 1700-1712q 28:8<1700-1712x 0923-7534 |
| 856 | 4 | u https://doi.org/10.1093/annonc/mdx308 |
| 856 | 4 8 | u https://gup.ub.gu.se/publication/256677 |
| 856 | 4 8 | u https://doi.org/10.1093/annonc/mdx308 |
| 856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:136351658 |
Hitta via bibliotek
- Annals of oncology : official journal of the European Society for Medical Oncolo... (Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- 20 av 35
- Föregående post
- Nästa post
- Till träfflistan
Hitta mer i SwePub
- Av författaren/redakt...
- Curigliano, G
- Burstein, H J
- P Winer, E
- Gnant, M
- Dubsky, P
- Loibl, S
- visa fler...
- Colleoni, M
- Regan, M M
- Piccart-Gebhart, ...
- Senn, H-J
- Thürlimann, B
- André, F
- Baselga, J
- Bergh, J
- Bonnefoi, H
- Y Brucker, S
- Cardoso, F
- Carey, L
- Ciruelos, E
- Cuzick, J
- Denkert, C
- Di Leo, A
- Ejlertsen, B
- Francis, P
- Galimberti, V
- Garber, J
- Gulluoglu, B
- Goodwin, P
- Harbeck, N
- Hayes, D F
- Huang, C-S
- Huober, J
- Hussein, K
- Jassem, J
- Jiang, Z
- Karlsson, Per, 1 ...
- Morrow, M
- Orecchia, R
- Osborne, K C
- Pagani, O
- Partridge, A H
- Pritchard, K
- Ro, J
- Rutgers, E J T
- Sedlmayer, F
- Semiglazov, V
- Shao, Z
- Smith, I
- Toi, M
- Tutt, A
- Viale, G
- Watanabe, T
- Whelan, T J
- Xu, B
- visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
- MEDICIN OCH HÄLS ...
- och Klinisk medicin
- och Cancer och onkol ...
- Artiklar i publikationen
- Annals of oncolo ...
- Annals of Oncolo ...
- Av lärosätet
- Göteborgs universitet
- Karolinska Institutet
Sök utanför SwePub
- Sök vidare i:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - Nationella bibliotekssystem
- LIBRIS.kb.se
